Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AVZO-021 / Avenzo Therap
ARTS-021-1001, NCT05867251: Study of AVZO-021 in Patients With Advanced Solid Tumors	Recruiting	1/2	430	US	AVZO-021, Palbociclib, Ibrance, Fulvestrant, Faslodex, Letrozole, Femara, Ribociclib, Kisqali, Abemaciclib, Verzenio, Carboplatin	Avenzo Therapeutics, Inc.	Advanced Solid Tumor	01/28	01/30